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Fungal infections and diseases predominantly affect patients with deregulated immu-
nity. Compelling experimental and clinical evidence indicate that severe fungal diseases
belong to the spectrum of fungus-related inﬂammatory diseases. Some degree of inﬂam-
mation is required for protection during the transitional response occurring temporally
between the rapid innate and slower adaptive response. However, progressive inﬂam-
mation worsens disease and ultimately prevents pathogen eradication. The challenge now
is to elucidate cellular and molecular pathways distinguishing protective vs. pathogenic
inﬂammation to fungi. In addition to fungal ligands of pattern recognition receptors
(pathogen-associated molecular patterns, PAMPs), several host-encoded proteins, the
damage-associated molecular patterns (DAMPs), are released during tissue injury and acti-
vate innate recognition receptors. DAMPs have been shown to regulate inﬂammation in
fungal diseases. The DAMP/receptor for advanced glycation end-products axis integrated
with the PAMP/Toll-like receptors axis in the generation of the inﬂammatory response in
experimental and clinical fungal pneumonia.These emerging themes better accommodate
fungal pathogenesis in the face of high-level inﬂammation seen in several clinical settings
and point to DAMP targeting as a novel immunomodulatory strategy in fungal diseases.
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INTRODUCTION
Fungi are associated with a wide spectrum of diseases in humans
and animals, ranging from acute self-limiting pulmonarymanifes-
tations and cutaneous lesions in immunocompetent individuals to
severe inﬂammatory diseases and life-threatening invasive infec-
tions in immunocompromised patients. Most fungi are ubiquitous
in the environment and humans are exposed by inhaling spores.
The ability to colonize almost every niche within the human
body involves speciﬁc reprogramming events to adapt to envi-
ronmental conditions (Cooney and Klein, 2008). In the case
of commensals, such as Malassezia spp. and Candida albicans,
co-evolution with their mammalian hosts for millions of years
implicates the existence of complex mechanisms of immune adap-
tations and, likewise, of sophisticated mechanisms to antagonize
immunity.
Indeed, most fungi are considered harmless in the context
of normal host responses indicating that a stable pathogen–host
interaction is common for microorganisms with inherently low
virulence. This implicates that a high degree of coexistence occurs
between fungi and their mammalian hosts, which deviates into
overt disease only under speciﬁc conditions, most prominently
deﬁcits in resistance and tolerance mechanisms, respectively,
deﬁned as the ability to limit pathogen burden or the damage
caused by the infection and/or the host (Romani, 2011).
INFLAMMATION: THE GOOD, THE BAD, AND THE UGLY
As in autoimmunity and chronic inﬂammation, an imbal-
ance between pro- and anti-inﬂammatory signals may prevent
successful host/fungal interaction, thus leading to infection and
disease (Romani and Puccetti, 2007). Indeed, despite the
occurrence of severe fungal infections in immunocompromised
patients, clinical evidence indicate that fungal diseases also occur
in the setting of an heightened inﬂammatory response, in which
immunity occurs at the expense of host damage and pathogen
eradication (Perfect, 2012). It is known that aberrant stimulation
of Toll-like receptors (TLRs) by damage-associated molecular pat-
terns (DAMPs) may result in increased expression of cytokines,
chemokines, and proteases, perpetuating a vicious inﬂammatory
cycle that constitutes the hallmark chronic inﬂammatory human
diseases (Srikrishna and Freeze, 2009; Piccinini and Midwood,
2010). We have recently described an additional mechanism by
which host inﬂammation may favor fungal infectivity and pro-
motes the transition from fungal commensalism to infection.
Fungal sensing of the mammalian cytokine interleukin (IL)-17A
induced artiﬁcial nutrient starvation conditions in C. albicans
and Aspergillus fumigatus, two major human fungal pathogens,
resulting in increased adhesion and ﬁlamentous growth that clin-
ically translates in a dramatic increment of bioﬁlm formation
and fungal virulence (Zelante et al., 2012). Thus, commensals or
ubiquitous fungi have evolved a contingency-based system during
co-evolution to guarantee their persistence in an inﬂammatory
host environment. The main implication of these ﬁndings is that,
at least in speciﬁc clinical settings, it is a heightened inﬂammatory
response that likely compromises a patient’s ability to eradicate
infection, and not an “intrinsic” susceptibility to infection that
determines a state of chronic or intractable diseases (Romani
and Puccetti, 2007). The conceptual principle highlighting a
truly bipolar nature of the inﬂammatory process in infection is
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best exempliﬁed by the occurrence of severe fungal infections
in patients with immune reconstitution syndrome, an entity
characterized by localized and systemic inﬂammatory reactions,
worsening disease in opportunistic and non-opportunistic infec-
tions, that are associated with immunological recovery (Gupta
and Singh, 2011; Perfect, 2012). Additionally, a high incidence
of fungal infections and sensitization to Aspergillus spp. has
been described in the hyper-IgE syndrome in which increased
levels of pro-inﬂammatory gene transcripts have been found
(Antachopoulos et al., 2007; Holland et al., 2007). Therefore, para-
doxically, increased inﬂammatory innate response may predispose
to either fungal infections or deregulated immune responses to the
fungus. Thus, fungal diseases represent an important paradigm
in immunology since they can result from either the lack of
recognition or over-activation of the inﬂammatory response.
INNATE RECOGNITION OF FUNGI
VIA PATHOGEN-ASSOCIATED MOLECULAR PATTERNS
Multiple cell populations and cell-signaling pathways are involved
in the antigen-independent recognition of the fungus by the
innate immune system. Applying systems biology approaches
to this complex process has resulted in a better appreciation
of the intricate cross-talk provided by temporal changes in
mediators, metabolites, and cell phenotypes underlining the
coordinated processes (Santamaria et al., 2011). Pattern recog-
nition receptors (PRRs) for fungal pathogen-associated molec-
ular patterns (PAMPs) include TLRs, C-type lectin receptors,
nucleotide oligomerization domain-like receptors (NLRs), and
NALP3 inﬂammasome (Romani, 2011; Figure 1). Both murine
and human studies have conﬁrmed the association of suscepti-
bility to fungal infections and diseases with genetic deﬁciency
of selected PRRs (Cunha et al., 2011a). By varying the compo-
sition with the morphotype, growth stage, environment sensing,
and fungal species, the cell wall provides the prime sources of
PAMPs that, as such, are ideal targets for recognition as non-self by
mammalian cells. To achieve optimal activation of antigen-speciﬁc
adaptive immunity, it is ﬁrst necessary to activate the pathogen-
detection mechanisms of the innate immune response. However,
by hyper-inducing pro-inﬂammatory cytokines, facilitating tissue
damage, or impairing protective immunity, PRR activation itself is
FIGURE 1 | Signaling pathways in fungal pathogen-associated
molecular patterns (PAMPs) recognition. PAMPs are recognized by
pattern recognition receptors (PRRs). The major PRRs are Toll-like receptors
(TLRs); C-type lectin receptors [CLRs; such as dectin 1, dectin 2, DC-speciﬁc
ICAM3 grabbing non-integrin (DC-SIGN), mincle, and the mannose receptor],
galectin family proteins (such as galectin 3), and the class B scavenger
receptor CD36. TLRs and CLRs activate multiple intracellular pathways
upon binding to speciﬁc fungal PAMPs, including β glucans [especially
β (1,3)-glucans with varying numbers of β (1,6) branches], chitin, a polymer
of N -acetylglucosamine, mannans linked to proteins through N or O linkages,
β (1,2) linked oligomannosides, and fungal nucleic acids. These signals
activate canonical or non-canonical nuclear factor-κB (NF-κB) and the
NOD, LRR- and pyrin domain-containing 3 (NLRP3) inﬂammasome,
and this culminates in the production of defensins, chemokines, cytokines,
and reactive oxygen species (ROS). CR3, complement receptor 3; ASC,
apoptosis-associated speck-like protein containing a CARD; BCL 10,
B cell lymphoma 10; CARD9, caspase recruitment domain-containing
protein 9; ERK, extracellular signal-regulated kinase; FcRγ, Fc receptor
γ chain; IL, interleukin; IRF3, IFN-regulatory factor 3; MALT1,
mucosa-associated lymphoid tissue lymphoma translocation protein 1;
MYD88, myeloid differentiation primary response protein 88; SYK, spleen
tyrosine kinase.
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a double-edged sword and this may explain why PMNs, although
essential in initiation and execution of the acute inﬂammatory
response and subsequent resolution, may act as double-edged
swords, as the excessive release of oxidants and proteases may
be responsible for injury to organs and fungal sepsis (Romani and
Puccetti, 2007).
VIA A DUAL SENSOR SYSTEM
There is a growing suspicion that there are additional types of
innate immune sensing mechanisms that are not based on pat-
tern recognition but rather on other principles. It is likely that
the kind of principles involved are similar to the “guard theory”
described in the plant immunity ﬁeld by Dangl and Jones (2001)
whereby the immune system senses the consequences of some
stereotypic function of a pathogen or virulence factor. That is,
instead of directly sensing the microbial structure, these sensors
detect unusual suspicious activities associated with the micro-
bial virulence apparatus. This kind of sensing has been proven to
complement pattern recognitionmechanisms in fungal infections.
Indeed, during inﬂammation, host- and fungal-derived proteases
trigger the activation of protease-activated receptors (PARs), a
family of G-protein-coupled receptors (Shpacovitch et al., 2007). It
has been shown that activation of TLRs by fungi unmasks an essen-
tial anddivergent role for PAR1 andPAR2 indownstream signaling
and inﬂammation (Figure 2). TLRs activated PARs and triggered
distinct signal transduction pathways involved in inﬂammation
and immunity to C. albicans and A. fumigatus. Inﬂammation
was promoted by PAR1 activation in response to Candida and
by PAR2 inhibition in response to Aspergillus. This occurred by
TLR regulation of PAR signaling. Thus, after recognition by TLRs,
PARs may become activated to sense proteolytic virulence fac-
tors and tissue injury, to mediate inﬂammatory responses and
modulate the activity of TLRs (Moretti et al., 2008). This impli-
cates that fungal recognition by TLRs may be licensed by DAMP
recognition (further discussed below). Conceptually, the model is
consistent with a binary signaling pathway of mammalian recog-
nition of fungi as observed in Drosophila. A fungal protease used
by the entomopathogenic fungus Beauveria bassiana to digest
the cuticle was shown to activate the Toll pathway by inducing
the maturation of Persephone into an active protease (Gottar
et al., 2006). Thus, many of the mechanisms used by the innate
immune system in animals show surprising parallels with those of
immunity in plants. Ultimately, sensing pathogen and virulence
is a dual sensor system to detect fungi that works throughout
evolution.
VIA DAMAGE-ASSOCIATED MOLECULAR PATTERNS
Inﬂammation results from recognition of PAMPs and DAMPs
(Gallucci and Matzinger, 2001). Despite the identiﬁcation of spe-
ciﬁc signaling pathways negatively regulating responses to PAMPs
or DAMPs (Bianchi, 2007), the unexpected convergence of molec-
ular pathways responsible for recognition of PAMPs and DAMPs
raised the question of whether and how the host discriminates
between PAMPs and DAMPs and the relative contribution of
either one to inﬂammation, immune homeostasis, and mecha-
nisms of repair during infection. It seems clear that the strategy
of innate immunity to identify and speciﬁcally respond to the
FIGURE 2 | Damage-associated molecular patterns (DAMP) signaling
in response to fungi. After TLR activation, protease-activated receptors
(PARs) sense proteolytic virulence factors and tissue injury and contribute
to fungal recognition through a dual sensor system. In addition, the
DAMP, S100B, through the spatio-temporal integration of signals from
TLRs and RAGE, allows the immune system to discriminate between
pathogen-derived and endogenous danger signals (see text for details).
TRIF, TIR domain-containing adaptor protein inducing IFN-β; MYD88,
myeloid differentiation primary response protein 88; RAGE, receptor for
advanced glycation end-products.
presence of a broad class of pathogens and injuries is based on
the existence of a set of PRRs that can discriminate between
PAMPs and DAMPs. The combined activation of these different
receptors by their speciﬁc ligands triggers signaling pathways that
can be complementary, synergistic, or antagonistic (Lee and Kim,
2007; Trinchieri and Sher, 2007). DAMPs such as the high mobil-
ity group box 1 protein and S100 proteins represent important
danger signals that, although primarily intracellular, may medi-
ate inﬂammatory responses through autocrine/paracrine inter-
actions with the receptor for advanced glycation end-products
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(RAGE), a multiligand receptor of the immunoglobulin super-
family (Schmidt et al., 2001; Donato, 2007; Sparvero et al., 2009).
Integral to the biology of RAGE and its ligands is their up-
regulation and increased accumulation in multiple biological and
disease settings. The ability to activate expression programs that
encode innate immune responsive genes confers to RAGE a cen-
tral role in chronic inﬂammatory diseases. Engagement of RAGE
converts a brief pulse of cellular activation to sustained cellu-
lar dysfunction, eventually leading to inﬂammation and tumor
promotion. However, because RAGE is expressed in multiple,
distinct cell types, including immune cells, and both murine
and human RAGE gene undergoes extensive splicing with dis-
tinct splice isoforms being uniquely distributed in different tissues
(Kalea et al., 2009), it is not surprising that diverse signal transduc-
tion and effector pathways may be impacted by RAGE depending
on sites, ligands and time course of ligand–RAGE stimulation
(Donato, 2007).
A mechanism that discriminates between fungi- and danger-
induced immune responses via the spatio-temporal integration
of signals from TLRs and RAGE has recently been described
(Figure 2). The mechanism exploits a previously unrecognized
role for the S100B/RAGE axis that, in sensing danger, plays a
critical and unanticipated role as a ﬁne modulator of inﬂam-
mation in experimental (Sorci et al., 2011) and human (Cunha
et al., 2011b) fungal pneumonia. By forming complexes with
various TLR ligands, S100B exhibited promiscuous activities at
the extracellular and intracellular levels. It inhibited TLR2 via
RAGE, through a paracrine epithelial cells/neutrophil braking
circuit, and this accounted for its anti-inﬂammatory activity in
infection. However, the ability of S100B to bind nucleic acids
resulted in the activation of intracellular TLRs converging on
TRIF and eventually resolving danger-induced inﬂammation via
transcriptional down-regulation of S100B gene expression. Thus,
in addition to the notion that danger signals may terminate
overactive immune responses (Sitkovsky and Ohta, 2005), our
study reveals that a pathogen-induced signal may also termi-
nate unnecessary danger-induced injury. A genetically determined
hyper-function of the DAMP signaling was indeed associated
with invasive aspergillosis in hematopoietic stem cell transplanted
patients (Cunha et al., 2011b) and with symptomatic Candida
vaginitis (Yano et al., 2012). Conceptually, our ﬁndings raise the
intriguing possibility that the host may have developed mech-
anisms to ameliorate the response to PAMPs via DAMPs. This
is also exempliﬁed by signaling through TLR3. In addition to
activation by viral double-stranded RNA, TLR3 can be acti-
vated by endogenous mRNA released by necrotic cells (Kariko
et al., 2004), a mechanism by which epithelial injury may lead to
inﬂammation. TLR3 plays a non-redundant role in the induc-
tion of immunological tolerance in fungal infections (De Luca
et al., 2007, 2010), a ﬁnding highlighting the contribution of
sensing danger in response to fungi. On a translational level,
targeting DAMP signaling may be of therapeutic beneﬁt in high-
risk patients. We have recently found that a hyper-function
of the DAMP signaling underlies inﬂammation in response to
airborne fungi in mice with cystic ﬁbrosis and obtained a proof-
of-concept demonstration that the inhibition of RAGE could be
of therapeutic beneﬁt in these mice (unpublished observations).
Together, these ﬁndings conﬁrm that an injudicious response to
PAMPs may result in a hostile environment to beneﬁcial commen-
sal fungi. Therefore, discrimination between pathogenic forms,
causing cellular damage and tissue injury, and innocuous com-
mensals may be critical in maintaining the balance and tissue
homeostasis.
DANGER SENSING IN RESPONSE TO FUNGI: THE PIVOTAL
ROLE OF INFLAMMASOMES
Among PRRs, the cytosolic NLR family member NLRP3 (also
known as NALP3, cryopyrin, and CIAS1) is a key player in host
defense against C. albicans (Gross et al., 2009; Hise et al., 2009;
Joly et al., 2009; Joly and Sutterwala, 2010). A role for NALP3
has also been shown in response to A. fumigatus (Said-Sadier
et al., 2010). NLRs are a family of intracellular proteins with a
tripartite modular structure that contain a central nucleotide-
binding oligomerization domain, a C-terminal LRR, and an
N-terminal effector-binding domain that shares structural sim-
ilarity with a subclass of plant disease resistance genes. Several
NLRs (NALPs and IPAF subfamilies) form multi-protein com-
plexes termed inﬂammasomes which activate inﬂammatory pro-
caspases and the subsequent processing and secretion of IL-1β,
IL-18, and IL-33 (Figure 1). As intracellular receptors, the NLR
family is in a prime location to detect danger signals associ-
ated with host stress and may therefore play a critical role in
recognizing the transition from commensal to pathogen (Joly
and Sutterwala, 2010). The activation of the NLRP3 inﬂam-
masome result in the activation of caspase-1 and processing
and secretion of IL-1β that mediates strong innate antifun-
gal responses and regulates Th1/Th17 cell activation (Bellocchio
et al., 2004; Vonk et al., 2006; Bozza et al., 2008; Hise et al.,
2009; van de Veerdonk et al., 2011). As a matter of fact, mice
deﬁcient for IL-1R (the receptor for IL-1β) are resistant and
mice with hyper-functioning of the IL-1β signaling are suscep-
tible to candidiasis. In addition, polymorphisms in the gene
coding for NLRP3 have been associated with recurrent vulvo-
vaginal candidiasis (Lev-Sagie et al., 2009), a ﬁnding consistent
with the notion that deregulated NLRP3 inﬂammasome activa-
tion is associated with both heritable and acquired inﬂammatory
diseases.
Currently, three models exist to explain NLRP3 inﬂammasome
activation: (a) lysosomal disintegration and release of its con-
tent by phagocytosed material; (b) induction of reactive oxygen
species production at mitochondrial membranes; and (c) potas-
sium efﬂux by membrane channels or ionophoric compounds
(Mankan et al., 2012). While it is accepted that C. albicans live
yeasts induce caspase-1-mediated IL-1β secretion in a NLRP3-
dependent manner (Gross et al., 2009; Hise et al., 2009; Joly et al.,
2009; Kumar et al., 2009), the precise pathways involved in NLRP3
inﬂammasome activation are yet to be deﬁned. Although hyphae
did not possess stimulatory properties, the ability of C. albicans
to transition from yeast to hyphal form was essential for NLRP3
activation (Joly et al., 2009). Thus, irrespective of the nature of
the ligands that activate NLRP3 in C. albicans infection, sensing
danger by the NLRP3 inﬂammasome, and likely NLRC4 (Tomalka
et al., 2011), is an inherent component of the host control of fungal
opportunism and infectivity.
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CONCLUSION
It is now clear that several DAMPs are vital danger signals
that alert the immune system to tissue damage upon fungal
infections. However, PRR activation by DAMPs may initiate
positive feedback loops where increasing tissue damage perpet-
uates pro-inﬂammatory responses leading to chronic inﬂamma-
tion. Indeed, DAMPs have been implicated in fungal diseases
where excessive inﬂammation plays a key role in pathogene-
sis, including fungal pneumonia in transplanted patients and
recurrent vulvovaginal candidiasis. Dissection of the reciprocal
regulation between DAMP and PAMP signaling pathways, and
the relative contribution of either one, in fungal diseases may
increase our understanding of the pathogenesis of these dis-
eases with the ultimate goal of developing new strategies that
target DAMPs to selectively modulate the immune response to
fungi.
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